Cargando…
Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
BACKGROUND: Abnormal miRNA and mRNA expression and dysregulated immune microenvironment have been found to frequently induce the progression of hepatocellular carcinoma (HCC) in recent reports. In particular, the immune-related competing endogenous RNAs (ceRNA) mechanism plays a crucial role in HCC...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035283/ https://www.ncbi.nlm.nih.gov/pubmed/36959615 http://dx.doi.org/10.1186/s12935-023-02888-9 |
_version_ | 1784911388799401984 |
---|---|
author | Lin, Xia-Hui Li, Dong-ping Liu, Zhi-Yong Zhang, Si Tang, Wen-qing Chen, Rong-xin Weng, Shu-qiang Tseng, Yu-jen Xue, Ru-yi Dong, Ling |
author_facet | Lin, Xia-Hui Li, Dong-ping Liu, Zhi-Yong Zhang, Si Tang, Wen-qing Chen, Rong-xin Weng, Shu-qiang Tseng, Yu-jen Xue, Ru-yi Dong, Ling |
author_sort | Lin, Xia-Hui |
collection | PubMed |
description | BACKGROUND: Abnormal miRNA and mRNA expression and dysregulated immune microenvironment have been found to frequently induce the progression of hepatocellular carcinoma (HCC) in recent reports. In particular, the immune-related competing endogenous RNAs (ceRNA) mechanism plays a crucial role in HCC progression. However, the underlying mechanisms remain unclear. METHODS: Differentially expressed immune-related genes were obtained from the Immport, GEO, and TCGA databases. The mRNA and protein expression levels in HCC tissues and adjacent normal tissues were confirmed, and we further investigated the methylation levels of these biomarkers to explore their function. Then, the TIMER and TISCH databases were used to assess the relationship between immune infiltration and hub genes. Survival analysis and univariate and multivariate Cox models were used to evaluate the association between hub genes and HCC diagnosis. Hub gene expression was experimentally validated in six HCC cell lines and 15 HCC samples using qRT-PCR and immunohistochemistry. The hub genes were uploaded to DSigDB for drug prediction enrichment analysis. RESULTS: We identified that patients with abnormal miRNAs (hsa-miR-125b-5p and hsa-miR-21-5p) and their targeted genes (NTF3, PSMD14, CD320, and SORT1) had a worse prognosis. Methylation analysis of miRNA-targeted genes suggested that alteration of methylation levels is also a factor in the induction of tumorigenesis. We also found that the development of HCC progression caused by miRNA-mRNA interactions may be closely correlated with the infiltration of immunocytes. Moreover, the GSEA, GO, and KEGG analysis suggested that several common immune-related biological processes and pathways were related to miRNA-targeted genes. The results of qRT-PCR, immunohistochemistry, and western blotting were consistent with our bioinformatics results, suggesting that abnormal miRNAs and their targeted genes may affect HCC progression. CONCLUSIONS: Briefly, our study systematically describes the mechanisms of miRNA-mRNA interactions in HCC and predicts promising biomarkers that are associated with immune filtration for HCC progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02888-9. |
format | Online Article Text |
id | pubmed-10035283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100352832023-03-24 Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation Lin, Xia-Hui Li, Dong-ping Liu, Zhi-Yong Zhang, Si Tang, Wen-qing Chen, Rong-xin Weng, Shu-qiang Tseng, Yu-jen Xue, Ru-yi Dong, Ling Cancer Cell Int Primary Research BACKGROUND: Abnormal miRNA and mRNA expression and dysregulated immune microenvironment have been found to frequently induce the progression of hepatocellular carcinoma (HCC) in recent reports. In particular, the immune-related competing endogenous RNAs (ceRNA) mechanism plays a crucial role in HCC progression. However, the underlying mechanisms remain unclear. METHODS: Differentially expressed immune-related genes were obtained from the Immport, GEO, and TCGA databases. The mRNA and protein expression levels in HCC tissues and adjacent normal tissues were confirmed, and we further investigated the methylation levels of these biomarkers to explore their function. Then, the TIMER and TISCH databases were used to assess the relationship between immune infiltration and hub genes. Survival analysis and univariate and multivariate Cox models were used to evaluate the association between hub genes and HCC diagnosis. Hub gene expression was experimentally validated in six HCC cell lines and 15 HCC samples using qRT-PCR and immunohistochemistry. The hub genes were uploaded to DSigDB for drug prediction enrichment analysis. RESULTS: We identified that patients with abnormal miRNAs (hsa-miR-125b-5p and hsa-miR-21-5p) and their targeted genes (NTF3, PSMD14, CD320, and SORT1) had a worse prognosis. Methylation analysis of miRNA-targeted genes suggested that alteration of methylation levels is also a factor in the induction of tumorigenesis. We also found that the development of HCC progression caused by miRNA-mRNA interactions may be closely correlated with the infiltration of immunocytes. Moreover, the GSEA, GO, and KEGG analysis suggested that several common immune-related biological processes and pathways were related to miRNA-targeted genes. The results of qRT-PCR, immunohistochemistry, and western blotting were consistent with our bioinformatics results, suggesting that abnormal miRNAs and their targeted genes may affect HCC progression. CONCLUSIONS: Briefly, our study systematically describes the mechanisms of miRNA-mRNA interactions in HCC and predicts promising biomarkers that are associated with immune filtration for HCC progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02888-9. BioMed Central 2023-03-23 /pmc/articles/PMC10035283/ /pubmed/36959615 http://dx.doi.org/10.1186/s12935-023-02888-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Lin, Xia-Hui Li, Dong-ping Liu, Zhi-Yong Zhang, Si Tang, Wen-qing Chen, Rong-xin Weng, Shu-qiang Tseng, Yu-jen Xue, Ru-yi Dong, Ling Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation |
title | Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation |
title_full | Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation |
title_fullStr | Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation |
title_full_unstemmed | Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation |
title_short | Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation |
title_sort | six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035283/ https://www.ncbi.nlm.nih.gov/pubmed/36959615 http://dx.doi.org/10.1186/s12935-023-02888-9 |
work_keys_str_mv | AT linxiahui siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT lidongping siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT liuzhiyong siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT zhangsi siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT tangwenqing siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT chenrongxin siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT wengshuqiang siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT tsengyujen siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT xueruyi siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation AT dongling siximmunerelatedpromisingbiomarkersmaypromotehepatocellularcarcinomaprognosisabioinformaticsanalysisandexperimentalvalidation |